InvestorsHub Logo
Followers 840
Posts 120475
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Friday, 02/25/2022 11:29:35 AM

Friday, February 25, 2022 11:29:35 AM

Post# of 1168
CHMP approves three new Opdivo indications with PD-L1 expression >=1%...

Opdivo monotherapy in adjuvant MIUC:
https://www.businesswire.com/news/home/20220223006231/en

Opdivo/Yervoy in first-line esophageal:
https://www.businesswire.com/news/home/20220224006058/en

Opdivo/chemo in first-line esophageal:
https://www.businesswire.com/news/home/20220224006066/en

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News